CPIM
AVDL

Columbia Partners Investment Management’s Avadel Pharmaceuticals AVDL Stock Holding History

Columbia Partners Investment Management’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-68,122
Closed -$831K – 326
2015
Q4 		$831K Sell
68,122
-255,594
-79% -$3.99M 0.06% 292
2015
Q3 		$5.28M Sell
323,716
-181,908
-36% -$4.01M 0.37% 104
2015
Q2 		$10.7M Buy
505,624
+414,346
+454% +$7.43M 0.66% 46
2015
Q1 		$1.64M Buy
+91,278
New +$1.43M 0.09% 208

Other funds holding AVDL

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.94% 1-Year Est. Return
FPC
Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Columbia Partners Investment Management's AVDL Position: Q1 2016 in Review

Columbia Partners Investment Management sold out of Avadel Pharmaceuticals (AVDL) in Q1 2016, closing a stake of 68,122 shares — an estimated $831K sold.

Columbia Partners Investment Management first reported a position in AVDL in Q1 2015 and held it in 4 quarters. The position peaked at $10.7M in Q2 2015. 81 funds tracked by Wall St. Rank hold AVDL as of Q1 2016.

  • Columbia Partners Investment Management reported no remaining Avadel Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Columbia Partners Investment Management sold 68,122 Avadel Pharmaceuticals shares in Q1 2016, an estimated $831K.
  • Columbia Partners Investment Management first reported a position in Avadel Pharmaceuticals in Q1 2015 and held it in 4 quarters.
  • Columbia Partners Investment Management's Avadel Pharmaceuticals position peaked at $10.7M in Q2 2015.
  • 81 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2016.

Based on Columbia Partners Investment Management's 13F filing for Q1 2016, filed 10 May 2016.